#earnings-results

[ follow ]
Healthcare
from24/7 Wall St.
1 week ago

One Rare Disease Biotech Posts 97% Margins but the Faster Growing Rival Just Turned Its First Profit

Two rare-disease biotechs show diverging trajectories: Corcept has slower growth with high margins but thin operating profit, while Amicus achieves faster growth and sustainable profitability.
from24/7 Wall St.
2 weeks ago

Micron Technology Stock Can Do No Wrong Right Now | MU Stock

The enthusiasm comes as Micron delivered remarkable Q1 FY2026 results, with revenue climbing 56.7% year-over-year to $13.64 billion and net income soaring 175.4% to $5.24 billion. The company's 38.4% net profit margin is stunning. Operating cashflow reached $8.41 billion in the quarter. Attention intensified following comments from Nvidia's CEO about AI storage demand, which sent memory chip stocks surging across the board.
Business
from24/7 Wall St.
2 weeks ago

The Lab Equipment Titan Trading at Half the Multiple Just Delivered Another Beat

Thermo Fisher posted Q3 revenue of $11.12 billion, up 4.9% year over year, and delivered $5.79 in earnings per share against estimates of $5.50. That marked the company's 14th earnings beat in the last 16 quarters. The consistency reflects a diversified product portfolio across scientific instruments, reagents, and consumables serving research labs, hospitals, and biopharma customers. Danaher's Q3 was more complicated. Revenue reached $6.05 billion, up 4.4%, and the company beat estimates with $1.89 per share versus $1.72 consensus.
Business
Business
from24/7 Wall St.
1 month ago

Compass Minerals Narrows Losses 65% as Revenue Climbs but Investors Stay Cautious

Compass Minerals narrowed Q4 losses, increased revenue year-over-year, and showed operational stabilization despite muted market reaction and mixed analyst sentiment.
Tech industry
from247wallst.com
2 months ago

Live: Coverage of Dell's Q3 Earnings

Dell faces growing AI-driven revenue but recurring post-earnings selloffs, postponed Project Maverick, and margin/execution risks that will test its fiscal Q3 2026 outlook.
Business
from24/7 Wall St.
3 months ago

Mondelez Sinks 6% After Earnings: Here's What You Need to Know

Record-high cocoa inflation sharply compressed Mondelez's margins, causing earnings decline and a revenue miss that drove a meaningful share-price drop.
Software development
fromYahoo Finance
4 months ago

Q2 Earnings Highs And Lows: Atlassian (NASDAQ:TEAM) Vs The Rest Of The Productivity Software Stocks

Productivity software stocks posted strong Q2 results with collective revenue beats and solid share gains; Atlassian showed robust revenue growth but mixed operational metrics.
from24/7 Wall St.
4 months ago

Why Buying NVIDIA Right Now May Mean Getting a Steal of a Deal

Make no mistake, Nvidia delivered a fantastic number, but let's not kid ourselves: expectations were heightened going into the quarter. Though Nvidia's figures signal that the ongoing AI revolution is still alive and well, the latest round of results lacked the awe factor that may now be needed to move the needle higher on a $4.25 trillion firm that the retail sector has been buying up aggressively in recent years.
Artificial intelligence
Artificial intelligence
from24/7 Wall St.
5 months ago

Is MongoDB's 38% Surge a Sneak Peek at Palantir's Next Big Leap to $200?

MongoDB's strong Q2 results and Atlas cloud growth signaled surging demand for AI data infrastructure, driving a 38% stock surge and raised guidance.
US Elections
from24/7 Wall St.
5 months ago

Nasdaq Composite Live: Markets Waiting on Powell's Jackson Hole Speech

Markets anticipate signals from the central bank regarding policy decisions in upcoming meetings.
fromFortune
5 months ago

Embattled BP beats on earnings as it touts selling oil, not cups of coffee, poking fun at its former CEO

"BP is much less interested in telling the public about the number of coffees it sells each year and is now focused on how much oil it can extract," Brooks said, poking at former CEO Bernard Looney.
Business
[ Load more ]